Hypothyroidism

Hypothyroidism is a condition in which the thyroid gland is underactive, resulting in a deficiency of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). In rare cases, hormone production may be sufficient, but thyroid hormones may have insufficient peripheral effects. Hypothyroidism may be congenital or acquired. If congenital, it is usually the result of thyroid dysplasia or aplasia. The etiology of acquired hypothyroidism is typically autoimmune (Hashimoto thyroiditis) or iatrogenic. The pathophysiology in hypothyroidism is characterized mainly by a reduction of the basal metabolic rate and generalized myxedema. Typical clinical findings include fatigue, cold intolerance, weight gain, and periorbital edema. More severe manifestations include myxedematous heart disease and myxedema coma, which may be fatal if left untreated. Children with congenital hypothyroidism often have umbilical hernias and, without early treatment, develop congenital iodine deficiency syndrome (intellectual disability, stunted growth). Accordingly, neonatal screening for hypothyroidism 24–48 hours after birth is required by law in most states. In adults, the diagnosis is established based on serum thyroid-stimulating hormone (TSH) and free T4 levels (FT4). Therapy for both acquired and congenital hypothyroidism consists of lifelong treatment with levothyroxine (L-thyroxine) and regular check-ups to monitor disease activity.

• Incidence: ∼ 1:2,300 newborns in the US (up to 1:2,000 worldwide) are affected by congenital hypothyroidism ^[1]
• Prevalence: more common in women
  • Women: up to 12:1,000
  • Men: up to 4:1,000 ^[2]

Epidemiological data refers to the US, unless otherwise specified.

Congenital hypothyroidism

• Sporadic (∼ 85% of cases) ^[3]
  • Thyroid hypoplasia, dysplasia, or ectopy
  • Thyroid aplasia (athyroidism)
  • Transplacental transmission of maternal antithyroid antibodies
  • Iodine deficiency
• Hereditary (∼ 15% of cases)
  • Dyshormonogenetic goiter: Defects in thyroid hormone synthesis (most commonly in thyroid peroxidase) lead to thyroid hyperplasia and goiter.
  • Peripheral resistance to thyroid hormones

Acquired hypothyroidism

• Primary hypothyroidism: insufficient thyroid hormone production
  • Hashimoto thyroiditis
    • The most common cause of hypothyroidism in iodine-sufficient regions ^[4]
    • Associated with other autoimmune diseases (e.g., vitiligo, pernicious anemia, type 1 diabetes mellitus, and systemic lupus erythematosus)
  • Postpartum thyroiditis (subacute lymphocytic thyroiditis) ^[4]
  • De Quervain thyroiditis (subacute granulomatous thyroiditis): often subsequent to a flu-like illness ^[4]
  • Iatrogenic: e.g., post thyroidectomy, radioiodine therapy, antithyroid medication (e.g., amiodarone, lithium)
  • Nutritional (insufficient intake of iodine): the most common cause of hypothyroidism worldwide, particularly in iodine-deficient regions
  • Riedel thyroiditis: occurs in IgG₄-related systemic disease
  • Wolff-Chaikoff effect
• Secondary hypothyroidism: pituitary disorders (e.g., pituitary adenoma) → TSH deficiency
• Tertiary hypothyroidism: hypothalamic disorders → TRH deficiency

Hypothalamic-pituitary-thyroid axis ^[5]

The hypothalamus, anterior pituitary gland, and thyroid gland, together with their respective hormones, comprise a self-regulatory circuit referred to as the “Hypothalamic-pituitary-thyroid axis.”

• Primary hypothyroidism: peripheral (thyroid) disorders → T3/T4 are not produced (↓ levels) → compensatory ↑ TSH
• Secondary hypothyroidism: pituitary disorders → ↓ TSH levels → ↓ T3/T4 levels
• Tertiary hypothyroidism: hypothalamic disorders → ↓ TRH levels → ↓ TSH levels → ↓ T3/T4 levels

Effects of hypothyroidism ^[5][6]

• Generalized decrease in the basal metabolic rate → decreased oxygen and substrate consumption, leading to:
  • CNS: apathy, slowed cognition
  • Skin and appendages: skin dryness, alopecia
  • Lipid profile: ↑ low-density lipoproteins, ↑ triglycerides
  • Cold intolerance
• Decreased sympathetic activity leads to:
  • Decreased sweating
  • Cold skin (due to decreased blood flow)
  • Constipation (due to decreased gastrointestinal motility)
  • Bradycardia
• Decreased transcription of sarcolemmal genes (e.g., calcium ATPases) → decreased cardiac output, myopathy
• Hyperprolactinemia: ↑ prolactin production is stimulated by TRH → suppression of LH, FSH, GnRH, and testosterone and stimulation of breast tissue growth
• Myxedema: due to accumulation of glycosaminoglycans and hyaluronic acid within the reticular layer of the dermis
  • Complex protein mucopolysaccharides bind water → nonpitting edema
  • Initially, edema is pretibial, but as the condition progresses it can generalize, resulting in a range of symptoms (see “Clinical features” below).

General signs and symptoms

• Symptoms related to decreased metabolic rate
  • Fatigue, decreased physical activity
  • Cold intolerance
  • Decreased sweating
  • Hair loss, brittle nails, and cold, dry skin
  • Weight gain (despite poor appetite)
  • Constipation
  • Bradycardia
  • Hypothyroid myopathy; , myalgia, stiffness, cramps
  • Woltman sign: a delayed relaxation of the deep tendon reflexes, which is commonly seen in patients with hypothyroidism, but can also be associated with advanced age, pregnancy, and diabetes mellitus.
  • Entrapment syndromes (e.g., carpal tunnel syndrome)
• Symptoms related to generalized myxedema
  • Doughy skin texture, puffy appearance
  • Myxedematous heart disease (dilated cardiomyopathy, bradycardia, dyspnea)
  • Hoarse voice, difficulty articulating words
  • Pretibial and periorbital edema
  • Myxedema coma (see “Complications” below)
• Symptoms of hyperprolactinemia
  • Abnormal menstrual cycle (esp. secondary amenorrhea; or menorrhagia)
  • Galactorrhea
  • Decreased libido, erectile dysfunction, delayed ejaculation, and infertility in men
• Further symptoms
  • Impaired cognition (concentration, memory), somnolence, depression
  • Hypertension ^[7]
  • Goiter (in Hashimoto thyroiditis) or atrophic thyroid (in atrophic thyroiditis)

Older patients may not have typical symptoms of hypothyroidism. Instead, they may appear to have dementia or depression.

Congenital hypothyroidism

Children with congenital hypothyroidism may have general signs and symptoms of hypothyroidism in addition to those typical in neonates (see below).

• Postpartum
  • Umbilical hernia
  • Prolonged neonatal jaundice
  • Hypotonia
  • Decreased activity, poor feeding, and adipsia
  • Hoarse cry, macroglossia
• Congenital iodine deficiency syndrome: a complication of congenital hypothyroidism that manifests leads to an impaired development of the brain and skeleton, resulting in skeletal abnormalities (e.g., short stature and delayed fontanelle closure) and intellectual disabilities ^[8]

Most children with congenital hypothyroidism do not have symptoms at the time of birth because the placenta supplies the fetus with maternal thyroid hormone. For this reason, neonatal screening is vital even if children are asymptomatic. Irreversible intellectual disabilities can be avoided through early initiation of adequate therapy!

To remember there characteristic manifestations of congenital iodine deficiency syndrome, think of the “7 P's”: Pot-bellied, Pale, Puffy-faced, Protruding umbilicus, Protuberant tongue, Poor brain development, and Prolonged neonatal jaundice.

Congenital hypothyroidism

Neonatal screening to measure TSH levels 24–48 hours after birth is required by law. Increased TSH levels indicate congenital hypothyroidism.

Acquired hypothyroidism

Basic diagnostic strategy

The initial step is to determine TSH levels, which may be followed by measurement of FT4 levels to confirm or rule out the suspected diagnosis.

Overview of changes in hormone levels

TSH is also altered in hyperthyroidism. However, in hyperthyroidism FT3 and FT4 would be increased.

Further diagnostic considerations ^[9]

A combination of the follwoing three diagnostic tools can be useful to distinguish between different conditions affecting the thyroid, such as differentiating exogenous from endogenous hyperthyroidism.

• Antibody testing
  • Tg Ab (thyroglobulin) and TPO Ab (thyroid peroxidase): detectable in most patients with autoimmune hypothyroidism
  • TRAb (TSH receptor)
    • Thyrotropin-binding inhibitory immunoglobulin assay (TBII assay)
      • Can detect antibodies against the TSH receptor, but cannot determine the type of antibody (blocking, neutral, or stimulating)
      • However, if a patient displays symptoms of hypothyroidism and antibodies are detected via the assay, it is highly likely that these are blocking antibodies.
• Radioactive iodine uptake test
  • Measures the proportion of exogenous iodine that is taken up by the thyroid (normally 10–35%)
  • Decreased uptake indicates hypothyroidism.
• Ultrasound of the thyroid gland: : e.g., to assess size, structure, or blood flow

Ruling out other conditions that can mimic hypothyroidism can be helpful in the diagnosis.

• Associated conditions
  • Hypercholesterolemia (increased LDL), hyperlipidemia, hypoglycemia
  • Increased creatine kinase
  • Mild anemia ^[10]
  • Possibly hyponatremia ^[11]

Normal TSH levels very likely rule out primary hypothyroidism and hyperthyroidism and are therefore the decisive parameter in screening for both conditions.

Euthyroid sick syndrome (ESS)

• Synonyms: sick euthyroid syndrome (SES), non-thyroidal illness syndrome (NTI)
• Etiology: occurs in severe illness or severe physical stress (most common in intensive care patients)
• Pathophysiology
  • Normal thyroid function → no symptoms of hyperthyroidism or hypothyroidism
  • Cytokines (e.g., interleukin 6) cause various changes in levels of circulating TSH and thyroid hormones.
    • Altered deiodinase enzyme activity
      • ↓ Conversion of T4 to T3
      • ↑ Conversion of T4 to reverse T3 (rT3) by thyroxine 5-monodeiodinase
      • ↓ Thyroid binding globulin
• Clinical features: specific to underlying nonthyroidal illness
• Laboratory
  • Low T3 syndrome: decrease in both total and FT3 levels, normal FT4 and TSH, and increased reverse T3
  • Low T3 low T4 syndrome: FT4 levels may be low in prolonged courses of illness (indicates a poor prognosis)
• Treatment
  • Treat underlying illness
  • Thyroid hormone replacement is usually not recommended because thyroid function is normal (there is not conclusive evidence that thyroid hormone substitution is beneficial to patients with ESS)

Thyroid hormone resistance ^[12]

• Definition: insufficient end-organ sensitivity to thyroid hormones
• Etiology: deficits in thyroid hormone metabolism, transport, or receptor interaction as a result of genetic mutations
• Clinical features: Symptoms of both hypothyroidism and hyperthyroidism are possible.
• Laboratory: Persistently elevated FT4 and FT3 and absent TSH suppression is typical.
• Therapy: No causative therapy is available.

The differential diagnoses listed here are not exhaustive.

L-thyroxine replacement ^[9]

• Drugs
  • L-thyroxine (levothyroxine, a synthetic form of T4): peripherally converted to T3 (biologically active) and rT3 (biologically inactive)
  • Liothyronine: synthetic form of triiodothyronine (T3)
• General principles
  • Lifelong replacement
  • Prompt initiation
• Indications
  • Myxedema
  • Hypothyroidism
• Side effects
  • Sweating, heat intolerance
  • Tachycardia; , palpitations, arrhythmias, chest pain
  • Tremors
  • Weight loss (this drug is sometimes misused by patients trying to lose weight)
• Interactions
  • Increased dosage necessary
    • Estrogen
    • SERM
    • Bile acid-binding resins
    • Omeprazole
    • Calcium carbonate
    • Phenytoin
    • Carbamazepine
    • Propranolol
  • Reduced dosage necessary: glucocorticoids
• Follow-ups with laboratory controls of thyroid function (TSH) at regular intervals; adjustment of dosage if necessary

Special considerations

• Children with congenital hypothyroidism: Normalization of thyroid hormone levels within 2–3 weeks is vital to prevent brain damage and developmental disorders. ^[16]
• Pregnant women with preexisting hypothyroidism: Levothyroxine dose must be increased but should be reduced to prepregnancy levels after delivery.
• Anorexic patients: Synthetic thyroid hormones are sometimes misused to achieve weight loss.
• Elderly patients or patients with preexisting cardiovascular conditions: Initiate levothyroxine with a lower dose and gradually increase the dose.
• L-thyroxine replacement in subclinical hypothyroidism if:
  • TSH ≥ 10 mU/L
  • TSH 7.0–9.9 mU/L in asymptomatic patients < 70 years
  • TSH above the upper limit of normal to 6.9 mU/L in symptomatic patients < 70 years

In pregnant women with hypothyroidism, L-thyroxine dose should be increased due to increased demand. Hypothyroidism adversely affects the development of the fetal nervous system.

Myxedema coma ^[17]

Myxedema coma is an extremely rare condition caused by the decompensation of an existing thyroid hormone deficiency and can be triggered by infections, surgery, and trauma. Myxedema coma is a potentially life-threatening condition and, if left untreated, is fatal in ∼ 40% of cases. ^[18]

• Clinical presentation
  • Cardinal symptoms: impaired mental status; , hypothermia; , and concurrent myxedema
  • Hypoventilation with hypercapnia
  • Hypotension (possibly shock) and bradycardia
• Diagnosis ^[19]
  • TSH and T4
  • Cortisol
  • Hypoglycemia and hyponatremia ^[20][21]
  • ↑ CK and LDH
  • ECG: low-voltage QRS complexes, flattened or inverted T waves
  • CSF analysis: slightly ↑ CSF protein
• Treatment
  • IV combination of levothyroxine and liothyronine plus IV hydrocortisone ^[22]
  • Patients should be treated and monitored in an ICU.

Upon clinical suspicion of myxedema coma, treatment must be initiated without waiting for laboratory results.

Further complications

• Primary thyroid lymphoma ^[23]
• Increased cardiovascular risk
• Carpal tunnel syndrome ^[24]

We list the most important complications. The selection is not exhaustive.